Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand.

Pathology - 1 Jan 2009

Pandey Sushil, Newton Sandie, Upton Arlo, Roberts Sally, Drinković Dragana

Abstract excerpt

AIMS: To describe the molecular basis of pyrazinamide (PZA) resistance among Mycobacterium tuberculosis in New Zealand, and to compare the pncA gene sequence among isolates with phenotypic (Bactec 960 and Wayne's assay) evidence of PZA resistance. METHODS: The pncA gene of 26 clinical isolates of M. tuberculosis found to be PZA resistant by phenotypic methods was sequenced. Phenotypic and genotypic data were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amidohydrolases
Share to Antitubercular Agents
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multigene Family

Share to Mycobacterium tuberculosis

Share to New Zealand

Share to Pyrazinamide

Share to Tuberculosis

Source

Identifiers

PMID: 19900109
DOI: 10.1080/00313020903071587

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand.PMID 19900109Read ↗

Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa.Semantic proximity Read ↗

pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal.Semantic proximity Read ↗

Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.Semantic proximity Read ↗

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.Semantic proximity Read ↗

Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.Semantic proximity Read ↗

pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of BrazilSemantic proximity Read ↗

High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda.Semantic proximity Read ↗

Characteristics of pncA mutations in multidrug-resistant tuberculosis in TaiwanSemantic proximity Read ↗

Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, ChinaSemantic proximity Read ↗

Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.Semantic proximity Read ↗

Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.